Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 20 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Klonizakis, Philippos  [Clear All Filters]
Journal Article
Mainou, M., Kotsiafti A., Klonizakis P., Soulountsi V., Apostolou C., Psarras K., et al. (2016).  A Case of Fatal Agranulocytosis That Developed in a Patient with β-Thalassemia Major Treated with Deferiprone.. Hemoglobin. 40(6), 435-437.
Sousos, N., Sinakos E., Klonizakis P., Adamidou D., Daniilidis A., Gigi E., et al. (2018).  Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre.. Br J Haematol. 181(1), 140-142.
Klonizakis, P., Klaassen R., Sousos N., Liakos A., Tsapas A., & Vlachaki E. (2017).  Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients. Annals of Hematology. 9635386959511886953716410511460363056271262012394215457(1111435131343Suppl 21151168618233445), 1937 - 1944.
Klonizakis, P., Klaassen R., Sousos N., Liakos A., Tsapas A., & Vlachaki E. (2017).  Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.. Ann Hematol. 96(11), 1937-1944.
Gavriilaki, E., Mainou M., Christodoulou I., Koravou E-E., Paleta A., Touloumenidou T., et al. (2017).   evidence of complement activation in patients with sickle cell disease.. Haematologica. 102(12), e481-e482.
Ioannidou-Papagiannaki, E., Diamantidis M. D., Livanis I., Klonizakis P., Haralambidou-Vranitsa S., Vlachaki E., et al. (2009).  Fatal chylous ascites, pericarditis and extensive venous thrombosis, due to an aggressive T cell non-Hodgkin lymphoma.. Ann Hematol. 88(4), 371-3.
Tselios, K., Klonizakis P., Sarantopoulos A., Gkougkourelas I., & Boura P. (2013).  Fatal refractory thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus.. J Clin Rheumatol. 19(7), 412-4.
Vlachaki, E., Agapidou A., Spanos G., Klonizakis P., Vetsiou E., Mavroudi M., et al. (2015).  Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.. Hemoglobin. 39(5), 299-304.
Kountouras, J., Deretzi G., Zavos C., Tsiptsios D., Gavalas E., Vardaka E., et al. (2011).  Helicobacter pylori infection may trigger Guillain-Barré syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis.. J Neurol Sci. 305(1-2), 167-8; author reply 169.
Kountouras, J., Chatzopoulos D., Zavos C., Polyzos S. A., Giartza-Taxidou E., Vardaka E., et al. (2012).  Helicobacter pylori infection might contribute to esophageal adenocarcinoma progress in subpopulations with gastroesophageal reflux disease and Barrett's esophagus.. Helicobacter. 17(5), 402-3.
Kountouras, J., Zavos C., Deretzi G., Polyzos S. A., Katsinelos P., Anastasiadou K., et al. (2011).  Helicobacter pylori might be a potential therapeutic target in epilepsy.. Med Hypotheses. 76(5), 763.
Kountouras, J., Deretzi G., Zavos C., Gavalas E., Polyzos S. A., Klonizakis P., et al. (2012).  Helicobacter pylori's potential association with epilepsy.. Seizure. 21(2), 151.
Diamantidis, M. D., Ioannidou-Papagiannaki E., Kountouras J., Mandala E., Tsapournas G., Frida-Michailidou I., et al. (2010).  High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes.. Acta Haematol. 124(3), 141-9.
Kountouras, J., Chatzopoulos D., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., et al. (2012).  Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma.. Surg Endosc. 26(1), 283-4.
Vetsiou, E., Mpouras V., Nikolaidou C., Klonizakis P., Mandala E., Vamvakis K., et al. (2020).  Necrobiosis Lipoidica in a Patient with β-Thalassemia Major: A Case Report and Review of the Literature.. Hemoglobin. 44(3), 221-223.
Gavriilaki, E., Christodoulou I., Koravou E-E., Paleta A., Koutra M., Zerva P., et al. (2018).  Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia.. Hemasphere. 2(5), e58.
Sousos, N., Adamidou D., Klonizakis P., Agapidou A., Theodoridou S., Spanos G., et al. (2017).  Presence of the IVS-I-6-Mutated Allele in Beta-Thalassemia Major Patients Correlates with Extramedullary Hematopoiesis Incidence.. Acta Haematol. 137(3), 175-182.
Vlachaki, E., Diamantidis M. D., Klonizakis P., Haralambidou-Vranitsa S., Ioannidou-Papagiannaki E., & Klonizakis I. (2012).  Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.. ScientificWorldJournal. 2012, 475313.
Apostolou, C., Klonizakis P., Mainou M., Kapsali E., Kafantari K., Kotsiafti A., et al. (2017).  Rivaroxaban Use in Patients with Hemoglobinopathies.. Hemoglobin. 41(3), 223-224.
Paschos, P., Vlachaki E., Pasvanti C., Sinakos E., Kalpaka A., Klonizakis P., et al. (2011).  Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.. Acta Haematol. 126(4), 231-3.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές